Skip to main content

Traumeel Prescribing Information

Package insert / product label
Dosage form: injection

Traumeel Description

Active Ingredients:

Ingredient name Potency Quantity Final dilution

Aconitum napellus 2X 1.32 μl 5.22X

Arnica montana, radix 2X 2.20 μl 5.00X

Bellis perennis 2X 1.10 μl 5.30X

Belladonna 2X 2.20 μl 5.00X

Calendula officinalis 2X 2.20 μl 5.00X

Chamomilla 3X 2.20 μl 6.00X

Echinacea 2X 0.55 μl 5.60X

Echinacea purpurea 2X 0.55 μl 5.60X

Hamamelis virginiana 1X 0.22 μl 5.00X

Hepar sulphuris calcareum 6X 2.20 μl 9.00X

Hypericum perforatum 2X 0.66 μl 5.52X

Mercurius solubilis 6X 1.10 μl 9.30X

Millefolium 3X 2.20 μl 6.00X

Symphytum officinale 6X 2.20 μl 9.00X

Indications and Usage for Traumeel

Treatment of injuries and various conditions of the musculoskeletal system.

• Traumeel® Injection Solution is a homeopathic drug product indicated for the treatment of injuries, inflammatory and degenerative conditions of the musculoskeletal system and for the relief of associated symptoms such as pain

Co-administration Therapy with Zeel® Injection Solution for the treatment of inflammatory and degenerative conditions of the musculoskeletal system.

• Traumeel ® Injection Solution is a homeopathic drug product indicated, in combination with Zeel® Injection Solution, for the treatment of inflammatory and degenerative conditions of the musculoskeletal system, such as arthrosis/osteoarthritis and/or rheumatic joint diseases, and for the relief of symptoms including pain, swelling, and joint stiffness.

Traumeel Dosage and Administration

General Considerations

  • The dosage schedules listed below can be used as a general guide for the administration of Traumeel® Injection Solution.
  • If co-administration with a local anesthetic is desired, Traumeel® Injection Solution may be mixed with lidocaine or similar agents at the discretion of the physician.

  • Traumeel® Injection Solution may be administered s.c., i.d., i.m., i.a. or i.v.
  • The interval between injections is left to the discretion of the HCP, but should not exceed 1 ampule in 24 hours.
  • Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Draw up the contents of the ampule into the syringe. Discard half or one third of the contents, depending on the required dosage, before administering.
  • Only licensed practitioners with sufficient expertise in injecting drugs, including the respective route of

    administration, should administer the product.

Standard Dosage - for the treatment of injuries, inflammatory and degenerative conditions of the musculoskeletal system and for the relief of associated symptoms such as pain.

Adults and children 12 years and older:

1 ampule 1 to 3 times per 7 days

Children 6 to 11 years:

2/3 of an ampule 1 to 3 times per 7 days

Children 2 to 5 years:

1/2 ampule 1 to 3 times per 7 days

Acute Dosage - for the treatment of injuries, inflammatory and degenerative conditions of the musculoskeletal system and for the relief of associated symptoms such as pain.

Adults and children 12 years and older:

1 ampule daily, and then continue with standard dosage

Children 6 to 11 years:

2/3 of an ampule daily, and then continue with standard dosage

Children 2 to 5 years:

1/2 ampule daily, and then continue with standard dosage

Co-administration therapy with Zeel® Injection Solution - for the treatment of inflammatory and degenerative conditions of the musculoskeletal system, such as arthrosis/osteoarthritis and/or rheumatic joint diseases, and for the relief of symptoms including pain, swelling, and joint stiffness.

  • In the treatment of musculoskeletal conditions, if co-administration with another homeopathic medicinal product is desired, Traumeel® Injection Solution may be mixed in a ratio of 1:1 with Zeel® Injection Solution.
  • For convenience, the daily dose of Traumeel® Injection Solution may be administered at the same time as a Zeel® Injection Solution, according to the dosing recommendations for each medication.

Contraindications

  • Traumeel® Injection Solution is contraindicated in patients with known hypersensitivity to Traumeel® or any of its ingredients.

Warnings and Precautions

None

Adverse Reactions/Side Effects


Post-marketing Experience

• The following adverse events have been identified during post-marketing use of Traumeel® Injection Solution. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

• Adverse event rates observed in Monotherapy use of Traumeel® Injection Solution: Allergic (hypersensitivity) reactions (e.g. skin allergies, redness/swelling at the injection site, even up to anaphylaxis) may occur in isolated cases.

• Adverse event rates observed in the Monotherapy use of Zeel® Injection Solution: Allergic (hypersensitivity) skin reactions may occur in isolated cases.

•To report SUSPECTED ADVERSE REACTIONS, contact MediNatura at 1.844.633.4628 or info@medinatura.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Overdosage

No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions.

Traumeel - Clinical Pharmacology

Mechanism of Action

The exact mechanism of Traumeel® Injection Solution is not fully understood.

Pharmacodynamics

Not applicable for homeopathic medicinal products.

Dosage Forms and Strengths

One ampule containing 2.2 ml each containing the active ingredients in the strengths listed under Description.

Traumeel 2.2ml Injection.jpg

TRAUMEEL
arnica montana root, atropa belladonna, calendula officinalis flowering top, matricaria recutita, achillea millefolium, calcium sulfide, comfrey root, aconitum napellus, bellis perennis, mercurius solubilis, hypericum perforatum, echinacea, unspecified, echinacea purpurea and hamamelis virginiana root bark/stem bark injection
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:50114-7004
Route of AdministrationINTRADERMAL, INTRAVENOUS, INTRAMUSCULAR, SUBCUTANEOUS, INTRA-ARTICULAR
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ARNICA MONTANA ROOT (UNII: MUE8Y11327) (ARNICA MONTANA ROOT - UNII:MUE8Y11327) ARNICA MONTANA ROOT2 [hp_X] in 2.2 mL
ATROPA BELLADONNA (UNII: WQZ3G9PF0H) (ATROPA BELLADONNA - UNII:WQZ3G9PF0H) ATROPA BELLADONNA2 [hp_X] in 2.2 mL
CALENDULA OFFICINALIS FLOWERING TOP (UNII: 18E7415PXQ) (CALENDULA OFFICINALIS FLOWERING TOP - UNII:18E7415PXQ) CALENDULA OFFICINALIS FLOWERING TOP2 [hp_X] in 2.2 mL
MATRICARIA RECUTITA (UNII: G0R4UBI2ZZ) (MATRICARIA RECUTITA - UNII:G0R4UBI2ZZ) MATRICARIA RECUTITA3 [hp_X] in 2.2 mL
ACHILLEA MILLEFOLIUM (UNII: 2FXJ6SW4PK) (ACHILLEA MILLEFOLIUM - UNII:2FXJ6SW4PK) ACHILLEA MILLEFOLIUM3 [hp_X] in 2.2 mL
CALCIUM SULFIDE (UNII: 1MBW07J51Q) (CALCIUM SULFIDE - UNII:1MBW07J51Q) CALCIUM SULFIDE6 [hp_X] in 2.2 mL
COMFREY ROOT (UNII: M9VVZ08EKQ) (COMFREY ROOT - UNII:M9VVZ08EKQ) COMFREY ROOT6 [hp_X] in 2.2 mL
ACONITUM NAPELLUS (UNII: U0NQ8555JD) (ACONITUM NAPELLUS - UNII:U0NQ8555JD) ACONITUM NAPELLUS2 [hp_X] in 2.2 mL
BELLIS PERENNIS (UNII: 2HU33I03UY) (BELLIS PERENNIS - UNII:2HU33I03UY) BELLIS PERENNIS2 [hp_X] in 2.2 mL
MERCURIUS SOLUBILIS (UNII: 324Y4038G2) (MERCURIUS SOLUBILIS - UNII:324Y4038G2) MERCURIUS SOLUBILIS6 [hp_X] in 2.2 mL
HYPERICUM PERFORATUM (UNII: XK4IUX8MNB) (HYPERICUM PERFORATUM - UNII:XK4IUX8MNB) HYPERICUM PERFORATUM2 [hp_X] in 2.2 mL
ECHINACEA, UNSPECIFIED (UNII: 4N9P6CC1DX) (ECHINACEA, UNSPECIFIED - UNII:4N9P6CC1DX) ECHINACEA, UNSPECIFIED2 [hp_X] in 2.2 mL
ECHINACEA PURPUREA (UNII: QI7G114Y98) (ECHINACEA PURPUREA - UNII:QI7G114Y98) ECHINACEA PURPUREA2 [hp_X] in 2.2 mL
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK (UNII: T7S323PKJS) (HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK - UNII:T7S323PKJS) HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK1 [hp_X] in 2.2 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:50114-7004-110 in 1 CARTON05/09/200712/31/2024
12.2 mL in 1 AMPULE; Type 0: Not a Combination Product
2NDC:50114-7004-23 in 1 CARTON05/09/200712/31/2024
22.2 mL in 1 AMPULE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic05/09/200712/31/2024
Labeler - Medinatura (102783016)
Establishment
NameAddressID/FEIBusiness Operations
Biologische Heilmittel Heel315635359manufacture(50114-7004)
Establishment
NameAddressID/FEIBusiness Operations
Hameln Pharma GmbH315869123manufacture(50114-7004)